PAMELA BERGERON: Open Payments
NPI 1235314063 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 14 payments from 5 companies in 2025. Trend: 2023 $307 · 2024 $229 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $115 |
| Astellas Pharma US Inc | 4 | $84 |
| Organon LLC | 3 | $52 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: MYFEMBREE, Veozah, NEXPLANON, Exparel, M-M-R II, GEMTESA.
Industry payments across TX — which companies pay providers there.
